Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Physician in the Loop

Physician in the Loop artwork

Daily Briefing for November 17, 2026

Nov 17, 20266 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Medicare proposes making Advantage plan doctors enroll in traditional Medicare The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source. Read the post and its sources Get the free email briefing The Centers for Medicare & Medicaid Services on Nov. 16 proposed requiring clinicians who bill Medicare Advantage plans to enroll in traditional Medicare, in a fraud rule it says would save nearly $90 billion. The proposal would also give every Medicare provider 30 days, down from as many as 90, to report changes to enrollment information, and would let the agency deny or revoke enrollment when an owner's or manager's identity cannot be confirmed, according to the agency's fact sheet. In a randomized study from Germany, physicians' accuracy fell as an AI tool was made to fail, and one in eight noticed without being asked. The New England Journal of Medicine published a phase 3 trial of semaglutide in children as young as 6, and FDA eased pregnancy-testing rules for isotretinoin. In this episode Medicare proposes requiring clinicians who bill Advantage plans to enroll in traditional Medicare and to report changes within 30 days Physicians' accuracy fell along with a failing AI's, and only one in eight noticed the tool breaking down, a randomized study finds Semaglutide lowered BMI 13.5% in children 6 to 11 with obesity, against a 2.7% rise on placebo, in a 68-week phase 3 trial CDC counts 112 measles cases in pregnancy and 13 cases of congenital measles since January 2025 FDA clears tubeless insulin pumps from MiniMed and Tandem, both cleared for up to seven days of wear and due in 2027 Two public glaucoma datasets used to validate AI share at least 1,031 identical eye scans, inflating reported accuracy Established vendors such as Microsoft and Epic took 68% of new ambient scribe spending in 2026, a survey-based report finds FDA eases isotretinoin's iPLEDGE rules, allowing home monthly pregnancy tests and ending monthly counseling records for some patients

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

Voice 1: This is Physician in the Loop, the daily briefing on AI in medicine. It's Tuesday, November 17th, 2026.

Voice 1: Medicare wants every clinician who bills a Medicare Advantage plan to also hold active enrollment in traditional Medicare, a proposed fraud rule CMS says would save nearly $90 billion.

Voice 2: Nearly $90 billion riding on an enrollment requirement. What does getting enrolled in traditional Medicare actually put someone through?

Voice 1: Identity verification, a licensure review, site visits, and fingerprint background checks. CMS is calling this the CRUSH rule, short for Comprehensive Regulations to Uncover Suspicious Healthcare, issued November 16th. The Advantage enrollment requirement itself wouldn't start until the plan year beginning two years after a final rule is published.

Voice 2: Two years out. Is there anything in here that actually lands on providers sooner than that?

Voice 1: Yes. Every Medicare provider, not just those billing Advantage plans, would get only 30 days to report a change to their enrollment information, down from as many as 90. CMS could also deny or revoke enrollment outright if an owner, manager, officer or director's identity can't be confirmed.

Voice 2: What's CMS's own side of the ledger look like, against that nearly $90 billion in savings?

Voice 1: About $380 million in costs from 2027 through 2036, by the agency's own estimate. And CMS said flatly it intends to put out a program integrity rule like this one every single year from now on.

Voice 2: A study out of Germany this week found something uncomfortable about leaning on AI. As researchers made an AI assistant fail on purpose, physicians' own accuracy fell right along with it, and almost nobody noticed without being asked.

Voice 1: Almost nobody noticed. How many people are we talking about, and how bad did the AI's reliability actually get?

Voice 2: Forty-eight participants, including 18 final-year medical students, classified 40 heart sounds while researchers dropped the tool's reliability in stages, from 90% down to 60%, then 50%, then 0%. Accuracy with the tool's help fell from about 81% down to about 58%.

Voice 1: Did it help at all when researchers made people commit to their own answer before seeing what the tool said?

Voice 2: No, it didn't improve performance. And their confidence in their own judgment actually fell faster than their trust in the tool kept falling.

Voice 1: So out of everyone in the study, how many actually caught the tool breaking down without being prompted to look for it?

Voice 2: About one in eight. The researchers, at Philipps-Universität Marburg, put it plainly: human oversight alone “may be insufficient to reliably detect system malfunctions.”

Voice 1: A trial out this week pushed semaglutide down into much younger patients. In children six to under twelve with obesity, once-weekly semaglutide cut body mass index by about 14% over 68 weeks, while kids on placebo saw their BMI rise about 3%.

Voice 2: That's a wide gap for kids that age. How many children were actually in this trial?

Voice 1: The STEP Young trial randomly assigned 167 children, two to one, with lifestyle counseling in both groups. 38% of the children on semaglutide ended up below the 95th percentile threshold for obesity, against just 2% on placebo.

Voice 2: Did that gap hold up over time, or close later on?

Voice 1: It widened. By 104 weeks, the difference between the groups reached nearly 18 percentage points. Gastrointestinal side effects were the most common problem, more frequent on semaglutide, and led one child to stop treatment.

Voice 2: Semaglutide's already approved for obesity in adolescents and adults. Worth saying Novo Nordisk, which makes the drug, funded this trial.

Voice 1: Funded or not, a gap that keeps widening two years in is the kind of result that gets noticed.

Voice 2: Measles turned up in a new place to worry about this week. CDC counted 112 confirmed measles cases during pregnancy, and 13 cases of congenital measles, from January of last year through late September.

Voice 1: Congenital measles in newborns. What complications actually came with that?

Voice 2: Maternal pneumonia, preterm delivery, and neonatal complications, according to the CDC's preliminary analysis.

Voice 1: Were most of these patients at least partly protected going in?

Voice 2: No. 98% of the pregnant patients hadn't gotten an MMR vaccine before pregnancy, or their vaccination status was unknown.

Voice 1: Is there anything else driving these cases, or does it really come down to that one gap?

Voice 2: The sources don't point to anything else. It comes down to that same vaccination gap, case after case.

Voice 1: Before we go, something to watch. The Senate's health committee votes November 18th on Heidi Overton, the nominee for FDA commissioner.

Voice 2: What actually happens if that vote goes her way?

Voice 1: Approval sends her nomination on to the full Senate, according to STAT.

Voice 2: One committee vote away from knowing who's actually running the agency behind rules like today's enrollment proposal.

Voice 1: Comments are also due November 24th on FDA's draft guidance for robotically assisted surgical devices.

Voice 2: What's that guidance actually asking for?

Voice 1: A risk assessment of AI features built into those devices, under docket FDA-2026-N-9505. The draft leaves out remote telesurgery and autonomous surgical robots entirely.

Voice 2: A guidance that draws its own line around what counts as robotic surgery, and leaves the fully autonomous version sitting outside it for now.

Voice 1: Sources and corrections are at physicianintheloop.org, where you can sign up for the free email briefing. This briefing was read by AI voices.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Special Topic: What changes on Jan. 1

    Nov 20, 20267 minAudio

    Laws in at least eight states that touch AI in health care take effect on Jan. 1. Most bind insurers and chatbot companies. A few, in California and Colorado, reach the practice itself. Read the special topic and its...

    Credit the people on this episode

  2. Friday Letter: On a short leash

    Nov 20, 20267 minAudio

    Software has begun to act for doctors, not just advise them. It should be kept on a short leash, because the doctor watching it rarely notices when it slips. Read the letter and its sources:...

    Credit the people on this episode

  3. Daily Briefing for November 20, 2026

    Nov 20, 20266 minAudio

    Hospitals race to patch a Java flaw found with AI in an hour The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source. Read...

    Credit the people on this episode

  4. Special Topic: Not the doctor's to sign

    Nov 19, 20267 minAudio

    Free AI tools for doctors come with a HIPAA contract one doctor can accept alone. A hospital's records need the hospital's signature, and the companies should make the safe path the default. Read the special topic and...

    Credit the people on this episode

  5. Daily Briefing for November 19, 2026

    Nov 19, 20267 minAudio

    AI hacking agents seize some networks in under 3 hours, FBI warns The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source....

    Credit the people on this episode